TNFRSF9 and neoplasm: As shown in Figure 6E and 6F, anti-PD-1 or anti-CD137 mAb had no anti-tumor efficacy as a single agent and cisplatin alone or a combination of anti-PD-1/CD137 mAbs only slightly suppressed tumor growth.